To confirm that the phosphorylation of AKT induces resistance to AZD5582, we examined the effects of AKT silencing via small interfering RNA (siRNA) on two pancreatic cancer cell lines, Capan-2 and AsPC-1. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.